XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 80 filers reported holding XENON PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $15,159,000 | -17.9% | 992,107 | 0.0% | 0.18% | -25.3% |
| Q2 2021 | $18,473,000 | +4.0% | 992,107 | 0.0% | 0.24% | -39.6% |
| Q1 2021 | $17,759,000 | +16.4% | 992,107 | 0.0% | 0.40% | -1.0% |
| Q4 2020 | $15,259,000 | +38.9% | 992,107 | 0.0% | 0.40% | -13.3% |
| Q3 2020 | $10,983,000 | -11.7% | 992,107 | 0.0% | 0.46% | -7.0% |
| Q2 2020 | $12,441,000 | +10.6% | 992,107 | 0.0% | 0.50% | -15.0% |
| Q1 2020 | $11,250,000 | -13.5% | 992,107 | 0.0% | 0.59% | -4.4% |
| Q4 2019 | $13,007,000 | +139.5% | 992,107 | +64.6% | 0.62% | +36.7% |
| Q3 2019 | $5,430,000 | +201.3% | 602,663 | +229.8% | 0.45% | +257.1% |
| Q2 2019 | $1,802,000 | – | 182,754 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |